Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer
1 other identifier
observational
35
1 country
1
Brief Summary
Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is a form of mastectomy that achieves optimal disease control and facilitates reconstruction. The study aimed to assess the oncological safety and aesthetic outcomes of nipple-sparing mastectomy and immediate breast reconstruction. 35 female patients with breast cancer were included in the study. The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 5, 2020
CompletedFirst Posted
Study publicly available on registry
November 23, 2020
CompletedNovember 23, 2020
November 1, 2020
2 years
November 5, 2020
November 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patients complications after nipple sparing mastectomy
Complete general examination, local examination of the skin, nipple and areola were done to determine whether the patients suffered from any complaints
2017-2019
Secondary Outcomes (1)
Aesthetic results assessed by Tzafetta et al scoring system
2017-2019
Interventions
The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.
Eligibility Criteria
The mean age of the studied patients was 44.00±9.47 years old; the youngest patient was 28 years old and the oldest one was 68 years old, the majority of patients were 40-50 years of age (54%) As regard the patients' marital status; 31 patients were married constituting 88.57 % and only 4 (11.4 %) patients were single The main complaint of 25 of them (71.42%) was painless breast lump while 8 cases (22.85%) presented with local recurrence after previous breast conservative surgery and only two case (5.7%) presented by extensive mammographic calcifications on screening mammography
You may qualify if:
- Diagnosis of ductal in situ carcinoma or infiltrating ductal carcinoma with a tumor diameter up to 3 cm
- Distance of the tumor from the nipple ≥ 2 cm
- Cancer or microcalcifications not localized in the central field.
- No blood secretions or other (nipple-areola complex) NAC disturbances
- Absence of skin involvement
- Indication to mastectomy for multifocal or diffuse microcalcifications
- Negative intraoperative assessment of NAC-bottom
You may not qualify if:
- Tumor or microcalcifications localized in the central quadrant or in the retroareolar region
- Blood secretions or other NAC alterations
- Positive intraoperative assessment of NAC-bottom
- Inflammatory carcinoma
- Paget's disease of the nipple
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria faculty of medicine
Alexandria, 21500, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2020
First Posted
November 23, 2020
Study Start
January 1, 2017
Primary Completion
January 1, 2019
Study Completion
January 1, 2019
Last Updated
November 23, 2020
Record last verified: 2020-11